TherapeuticsMD, Inc. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
10QSB
144
25
3
3/A
4
4/A
424B2
424B3
424B5
424B7
5
8-A12B
8-K
8-K/A
ARS
AW
CERTNAS
CERTNYS
CORRESP
CT ORDER
D
DEF 14A
DEF 14C
DEFA14A
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
POSASR
PRE 14A
PRE 14C
PREM14A
PRER14A
PRER14C
S-1
S-3
S-3ASR
S-3MEF
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14D9
SC 14D9/A
SC TO-C
SC TO-I
SC TO-I/A
SC TO-T
SC TO-T/A
SC14D9C
SCHEDULE 13G
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC TO-T | SC TO-T | 0001193125-22-168449 | Jun 6, 2022 | — |
| 8-K/A | 8-K/A | 0001564590-22-022527 | Jun 6, 2022 | May 27, 2022 |
| 8-K | 8-K | 0001564590-22-022465 | Jun 3, 2022 | May 27, 2022 |
| SC 13G | — | 0000935836-22-000362 | Jun 3, 2022 | — |
| 8-K | 8-K | 0001564590-22-021755 | May 31, 2022 | May 27, 2022 |
| SC14D9C | SC14D9C | 0001193125-22-163068 | May 31, 2022 | — |
| SC TO-C | SC TO-C | 0001193125-22-162948 | May 31, 2022 | — |
| 8-K | 8-K | 0001564590-22-020824 | May 20, 2022 | — |
| 10-Q | 10-Q | 0001564590-22-020440 | May 16, 2022 | Mar 31, 2022 |
| 8-K | 8-K | 0001564590-22-020389 | May 16, 2022 | — |
| 8-K | 8-K | 0001564590-22-018687 | May 9, 2022 | May 3, 2022 |
| 10-K/A | 10-K/A | 0001564590-22-016823 | Apr 29, 2022 | Dec 31, 2021 |
| 8-K | 8-K | 0001564590-22-016083 | Apr 27, 2022 | — |
| 8-K | 8-K | 0001564590-22-014927 | Apr 20, 2022 | Apr 14, 2022 |
| 8-K | 8-K | 0001564590-22-014472 | Apr 14, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-22-021795 | Mar 31, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-22-021793 | Mar 31, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-22-021792 | Mar 31, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-22-021794 | Mar 31, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-22-021211 | Mar 28, 2022 | Mar 23, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-021212 | Mar 28, 2022 | Mar 23, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-021208 | Mar 28, 2022 | Mar 23, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-021209 | Mar 28, 2022 | Mar 23, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-021210 | Mar 28, 2022 | Mar 23, 2022 |
| POS AM | POS AM | 0001193125-22-082932 | Mar 24, 2022 | — |
| POSASR | POSASR | 0001193125-22-082798 | Mar 23, 2022 | — |
| 10-K | 10-K | 0001564590-22-011525 | Mar 23, 2022 | Dec 31, 2021 |
| SC 13D/A | AMENDMENT TO FORM SC 13D | 0001387131-22-003889 | Mar 23, 2022 | — |
| 8-K | 8-K | 0001564590-22-011090 | Mar 18, 2022 | Mar 14, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-018682 | Mar 15, 2022 | Mar 14, 2022 |
| 8-K | 8-K | 0001564590-22-009476 | Mar 10, 2022 | Mar 6, 2022 |
| 8-K | 8-K | 0001564590-22-008860 | Mar 7, 2022 | — |
| 8-K | 8-K | 0001564590-22-005710 | Feb 18, 2022 | Feb 17, 2022 |
| SC 13G/A | — | 0000080255-22-002012 | Feb 14, 2022 | — |
| SC 13G/A | — | 0000834237-22-003903 | Feb 1, 2022 | — |
| 8-K | 8-K | 0001564590-22-000008 | Jan 3, 2022 | Dec 28, 2021 |
| 8-K | 8-K | 0001564590-21-060676 | Dec 20, 2021 | Dec 14, 2021 |
| 8-K | 8-K | 0001564590-21-060654 | Dec 17, 2021 | Dec 13, 2021 |
| 8-K | 8-K | 0001564590-21-060036 | Dec 10, 2021 | — |
| 8-K | 8-K | 0001564590-21-059685 | Dec 8, 2021 | Dec 7, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-21-067391 | Dec 2, 2021 | Nov 30, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-21-066002 | Nov 22, 2021 | Nov 18, 2021 |
| 8-K/A | 8-K/A | 0001564590-21-057142 | Nov 16, 2021 | Nov 11, 2021 |
| 8-K | 8-K | 0001564590-21-056427 | Nov 12, 2021 | Nov 11, 2021 |
| 10-Q | 10-Q | 0001564590-21-056434 | Nov 12, 2021 | Sep 30, 2021 |
| S-8 | S-8 | 0001564590-21-050961 | Oct 15, 2021 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-21-060607 | Oct 15, 2021 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-21-060610 | Oct 15, 2021 | — |
| SC TO-I/A | SC TO-I/A | 0001193125-21-289853 | Oct 1, 2021 | — |
| 8-K | 8-K | 0001564590-21-049852 | Oct 1, 2021 | Sep 30, 2021 |